The first Ebola vaccine has been administered to 20 healthy adults in clinical trials in the United States, researchers.
The trial vaccine was developed through collaboration of the National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, and Okairos, a Swiss-Italian biotech company recently acquired by the pharmaceutical company GlaxoSmithKline, German Press Agency dpa reported.
The vaccine was first successfully tested on monkeys ahead of the 48-week trial on human participants between the ages of 18 and 50.
There is no danger that the participants can become infected with the disease, NIAID said.
GMT 13:50 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 13:20 2018 Monday ,29 October
National campaign to raise awareness of breast cancerGMT 14:34 2018 Friday ,19 October
Birth spacing "improving health of Omani women"GMT 15:35 2018 Thursday ,11 October
Russia to discuss issue of biological labs near its bordersGMT 16:14 2018 Saturday ,29 September
Premier Khalifa bin Salman congratulated by health ministerGMT 16:10 2018 Saturday ,29 September
Bahrain to host Dermatology, Laser and Aesthetics ConferenceGMT 12:44 2018 Friday ,28 September
EU proposes €40 million for UNRWA to keep health clinics openGMT 07:46 2018 Wednesday ,26 September
HRH Premier to address UN high-level health meetingsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor